Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127653 | SCV000171232 | benign | not specified | 2013-06-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000127653 | SCV000309202 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001812106 | SCV001160202 | benign | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002055762 | SCV002444123 | benign | RASopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381441 | SCV002699531 | likely benign | Cardiovascular phenotype | 2014-12-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002505096 | SCV002806687 | likely benign | Noonan syndrome 1; Juvenile myelomonocytic leukemia; Metachondromatosis; LEOPARD syndrome 1 | 2021-12-08 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315856 | SCV004017222 | benign | Juvenile myelomonocytic leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing |